The estrogen commonly used for hormone replacement therapy in menopausal women is: A. Ethinylestradiol B. Estradiol benzoate C. Diethylstilbestrol D. Conjugated estrogens

The estrogen commonly used for hormone replacement therapy in menopausal women is:
A. Ethinylestradiol
B. Estradiol benzoate
C. Diethylstilbestrol
D. Conjugated estrogens
by

1 Answer

Answer :

D. Conjugated estrogen
by

Related questions

Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial infarction due to estrogen B. Blocks the increased risk of endometrial carcinoma due to estrogen C. Reverses vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Description : Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial ... vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Last Answer : The estrogen commonly used for hormone replacement therapy in menopausal women is: A. Ethinylestradiol B. Estradiol benzoate C. Diethylstilbestrol D. Conjugated estrogens

Which of the following statements most closely reflects the current status of estrogens in postmenopausal women: A. Estrogens should be prescribed routinely to all menopausal women B. Estrogens should be prescribed when menopausal symptoms are severe C. Estrogens should be prescribed only when there is radiological evidence of osteoporosis D. Estrogens should be prescribed along with a progestin after considering risk:benefit ratio in individual patients

Description : Which of the following statements most closely reflects the current status of estrogens in postmenopausal women: A. Estrogens should be prescribed routinely to all menopausal women B. ... should be prescribed along with a progestin after considering risk:benefit ratio in individual patients

Last Answer : . Estrogens should be prescribed along with a progestin after considering risk:benefit ratio in individual patients

Transdermal estradiol differs from oral estrogen therapy in that it: A. Causes less induction of hepatic synthesis of clotting factors B. Does not inhibit FSH secretion C. Does not affect vaginal cytology D. All of the above are correct

Description : Transdermal estradiol differs from oral estrogen therapy in that it: A. Causes less induction of hepatic synthesis of clotting factors B. Does not inhibit FSH secretion C. Does not affect vaginal cytology D. All of the above are correct

Last Answer : A. Causes less induction of hepatic synthesis of clotting factors

Select the correct statement about tibolone: A. It is an antiestrogen used for palliative treatment of carcinoma breast B. It is an estrogenic + progestational steroid used for hormone replacement therapy in postmenopausal women C. It is an antiandrogen used for male pattern baldness D. It is a nonsteroidal estrogen used topically for senile vaginitis

Description : Select the correct statement about tibolone: A. It is an antiestrogen used for palliative treatment of carcinoma breast B. It is an estrogenic + progestational steroid used for hormone replacement ... for male pattern baldness D. It is a nonsteroidal estrogen used topically for senile vaginitis

Last Answer : B. It is an estrogenic + progestational steroid used for hormone replacement therapy in postmenopausal women

Select the compound which used for hormone replacement therapy in postmenopausal women serves the purpose of both estrogen and progestin with weak androgenic activity: A. Tibolone B. Mestranol C. Desogestrel D. Gestodene

Description : Select the compound which used for hormone replacement therapy in postmenopausal women serves the purpose of both estrogen and progestin with weak androgenic activity: A. Tibolone B. Mestranol C. Desogestrel D. Gestodene

Last Answer : A. Tibolone

The daily dose of estrogen for hormone replacement therapy in postmenopausal women is: A. Same as for contraception B. Higher than that for contraception C. Lower than that for contraception D. Variable depending on the age of the woman

Description : The daily dose of estrogen for hormone replacement therapy in postmenopausal women is: A. Same as for contraception B. Higher than that for contraception C. Lower than that for contraception D. Variable depending on the age of the woman

Last Answer : C. Lower than that for contraception

The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes

Description : The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes

Last Answer : C. It has additional androgenic acitivity

In which of the following conditions estrogen is not the primary drug but is added to progestin as adjuvant: A. Dysfunctional uterine bleeding B. Menopausal syndrome C. Osteoporosis D. Atrophic vaginitis

Description : In which of the following conditions estrogen is not the primary drug but is added to progestin as adjuvant: A. Dysfunctional uterine bleeding B. Menopausal syndrome C. Osteoporosis D. Atrophic vaginitis

Last Answer : A. Dysfunctional uterine bleeding

Select the progestin preparation for coadministration with estrogen for hormone replacement therapy that does not counteract the beneficial effect of the latter on lipid profile due to lack of androgenic activity: A. Micronized oral progesterone B. Norethindrone C. Lynestrenol D. Medroxyprogesterone acetate (p. 281-282)

Description : Select the progestin preparation for coadministration with estrogen for hormone replacement therapy that does not counteract the beneficial effect of the latter on lipid profile due to lack of ... oral progesterone B. Norethindrone C. Lynestrenol D. Medroxyprogesterone acetate (p. 281-282)

Last Answer : Select the indication for which a progestin is used alone without combining with an estrogen: A. Threatened abortion B. Dysfunctional uterine bleeding C. Hormone replacement therapy D. Premenstrual tension

Select the option which correctly matches the endocrine gland with its hormone and its function. Endocrine Hormone Function gland (a) Placenta Estrogen Initiates secretion of the milk (b) Corpus Estrogen Essential for luteum maintenance of endometrium (c) Leydig’s Androgen Initiates the cells production of sperms (d) Ovary FSH Stimulates follicular development and the secretion of estrogens

Description : Select the option which correctly matches the endocrine gland with its hormone and its function. Endocrine Hormone Function gland (a) Placenta Estrogen Initiates secretion of the milk (b) Corpus ... of sperms (d) Ovary FSH Stimulates follicular development and the secretion of estrogens

Last Answer : (c) Leydig’s Androgen Initiates the cells production of sperms

Which of the following hormones is primarily responsible for stimulating the production of progesterone? a) Luteinizing hormone Luteinizing hormone is released by the pituitary gland. b) Follicle-stimulating hormone Follicle-stimulating hormone is responsible for stimulating the ovaries to secrete estrogen. c) Estrogen Estrogens are responsible for developing and maintaining the female reproductive tract. d) Androgen Androgens, secreted in small amounts by the ovaries, are involved in early development of the follicle and also affect the female libido.

Description : Which of the following hormones is primarily responsible for stimulating the production of progesterone? a) Luteinizing hormone Luteinizing hormone is released by the pituitary gland. b) Follicle-stimulating ... , are involved in early development of the follicle and also affect the female libido.

Last Answer : a) Luteinizing hormone Luteinizing hormone is released by the pituitary gland.

Benefits of tamoxifen citrate therapy include the following except: A. Reduction in recurrence rate of breast cancer B. Improved bone mass C. Suppression of menopausal hot flushes D. Improved lipid profile

Description : Benefits of tamoxifen citrate therapy include the following except: A. Reduction in recurrence rate of breast cancer B. Improved bone mass C. Suppression of menopausal hot flushes D. Improved lipid profile

Last Answer : C. Suppression of menopausal hot flushes

Stein-leventhal syndrome is due to overproduction of (A) Estrogens (B) Androgens (C) Gastogens (D) Ethinyl estradiol

Description : Stein-leventhal syndrome is due to overproduction of (A) Estrogens (B) Androgens (C) Gastogens (D) Ethinyl estradiol

Last Answer : Answer : B

Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with: A. Leg vein thrombosis B. Undiagnosed vaginal bleeding C. Migraine D. All of the above

Description : Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with: A. Leg vein thrombosis B. Undiagnosed vaginal bleeding C. Migraine D. All of the above

Last Answer : D. All of the above

Estrogen therapy in postmenopausal women has been implicated in increasing the risk of the following disorders except: A. Gall stones B. Osteoporosis C. Endometrial carcinoma D. Breast cancer

Description : Estrogen therapy in postmenopausal women has been implicated in increasing the risk of the following disorders except: A. Gall stones B. Osteoporosis C. Endometrial carcinoma D. Breast cancer

Last Answer : B. Osteoporosis

Which of the following is a reversible cause of urinary incontinence in the older adult? a) Constipation. Constipation is a reversible cause of urinary incontinence in the older adult. Other reversible causes include acute urinary tract infection, infection elsewhere in the body, decreased fluid intake, a change in a chronic disease pattern, and decreased estrogen levels in the menopausal women.

Description : Which of the following is a reversible cause of urinary incontinence in the older adult? a) Constipation. Constipation is a reversible cause of urinary incontinence in the older adult. Other ... level in the menopausal woman is a reversible cause of urinary incontinence in the older woman.

Last Answer : a) Constipation. Constipation is a reversible cause of urinary incontinence in the older adult. Other reversible causes include acute urinary tract infection, infection elsewhere in the body, decreased ... a change in a chronic disease pattern, and decreased estrogen levels in the menopausal women.

The regimen(s) used for postcoital emergency contraception is/are: A. Levonorgestrel 0.5 mg + ethinylestradiol 0.1 mg taken twice 12 hour apart B. Levonorgestrel 0.75 mg taken twice 12 hour apart C. Mifepristone 600 mg single dose D. All of the abov

Description : The regimen(s) used for postcoital emergency contraception is/are: A. Levonorgestrel 0.5 mg + ethinylestradiol 0.1 mg taken twice 12 hour apart B. Levonorgestrel 0.75 mg taken twice 12 hour apart C. Mifepristone 600 mg single dose D. All of the abov

Last Answer : D. All of the abov

16.14 Menotropins is a preparation of: A. FSH + LH obtained from urine of menstruating women B. LH obtained from urine of pregnant women C. FSH + LH obtained from urine of menopausal women D. LH obtained from serum of pregnant mare (p. 219

Description : 16.14 Menotropins is a preparation of: A. FSH + LH obtained from urine of menstruating women B. LH obtained from urine of pregnant women C. FSH + LH obtained from urine of menopausal women D. LH obtained from serum of pregnant mare (p. 219

Last Answer : C. FSH + LH obtained from urine of menopausal women

Addition of a progestin for 10-12 days every month to cyclic estrogen replacement therapy during menopause is recommended because the progestin: A. Prevents osteoporosis B. Prevents irregular bleeding C. Blocks increased risk of endometrial carcinoma D. Both ‘B’ and ‘C’ are correct

Description : Addition of a progestin for 10-12 days every month to cyclic estrogen replacement therapy during menopause is recommended because the progestin: A. Prevents osteoporosis B. Prevents irregular bleeding C. Blocks increased risk of endometrial carcinoma D. Both ‘B’ and ‘C’ are correct

Last Answer : D. Both ‘B’ and ‘C’ are correct

Estrogen therapy can worsen the following associated conditions except: A. Migraine B. Cholelithiasis C. Acne vulgaris D. Endometriosis

Description : Estrogen therapy can worsen the following associated conditions except: A. Migraine B. Cholelithiasis C. Acne vulgaris D. Endometriosis

Last Answer : C. Acne vulgaris

Duodenum has characteristic Brunner’s gland which secrete two hormones called (a) kinase, estrogen (b) secretin, cholecystokinin (c) prolactin, parathormone (d) estradiol, progesterone

Description : Duodenum has characteristic Brunner’s gland which secrete two hormones called (a) kinase, estrogen (b) secretin, cholecystokinin (c) prolactin, parathormone (d) estradiol, progesterone

Last Answer : (b) secretin, cholecystokinin

Bone resorption is accelerated by: A. Estrogens B. Parathormone C. Bisphosphonates D. Calcitonin

Description : Bone resorption is accelerated by: A. Estrogens B. Parathormone C. Bisphosphonates D. Calcitonin

Last Answer : B. Parathormone

Estrogens are palliative in the following malignancy: A. Carcinoma breast B. Carcinoma cervix C. Endometrial carcinoma D. Carcinoma prostate

Description : Estrogens are palliative in the following malignancy: A. Carcinoma breast B. Carcinoma cervix C. Endometrial carcinoma D. Carcinoma prostate

Last Answer : D. Carcinoma prostate

Metabolic actions of estrogens tend to cause the following except: A. Anabolism B. Impaired glucose tolerance C. Rise in plasma LDL-cholesterol D. Salt and water retention

Description : Metabolic actions of estrogens tend to cause the following except: A. Anabolism B. Impaired glucose tolerance C. Rise in plasma LDL-cholesterol D. Salt and water retention

Last Answer : C. Rise in plasma LDL-cholesterol

Estrogens exert the following actions except: A. Cornification of vaginal epithelium B. Proliferation of endometrium C. Maturation of graafian follicle D. Anabolism

Description : Estrogens exert the following actions except: A. Cornification of vaginal epithelium B. Proliferation of endometrium C. Maturation of graafian follicle D. Anabolism

Last Answer : C. Maturation of graafian follicle

Apraclonidine is a clonidine congener which is used: A. To suppress opioid withdrawal syndrome B. To suppress menopausal syndrome C. As Analgesic D. To reduce intraocular tension

Description : Apraclonidine is a clonidine congener which is used: A. To suppress opioid withdrawal syndrome B. To suppress menopausal syndrome C. As Analgesic D. To reduce intraocular tension

Last Answer : D. To reduce intraocular tension

Apraclonidine is a clonidine congener which is used: A. To suppress opioid withdrawal syndrome B. To suppress menopausal syndrome C. As Analgesic D. To reduce intraocular tension

Description : Apraclonidine is a clonidine congener which is used: A. To suppress opioid withdrawal syndrome B. To suppress menopausal syndrome C. As Analgesic D. To reduce intraocular tension

Last Answer : D. To reduce intraocular tension

What is true of tamoxifen: A. It can induce endometrial proliferation in postmenopausal women B. It exerts antiestrogenic activity in bone C. It raises LDL-cholesterol levels D. It is ineffective in estrogen receptor-negative breast cancer

Description : What is true of tamoxifen: A. It can induce endometrial proliferation in postmenopausal women B. It exerts antiestrogenic activity in bone C. It raises LDL-cholesterol levels D. It is ineffective in estrogen receptor-negative breast cancer

Last Answer : A. It can induce endometrial proliferation in postmenopausal women

Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate

Description : Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate

Last Answer : B. Raloxifene

Chlorpromazine therapy increases the secretion of the following hormone: A. Prolactin B. Gonadotropin C. Corticotropin D. Antidiuretic hormone

Description : Chlorpromazine therapy increases the secretion of the following hormone: A. Prolactin B. Gonadotropin C. Corticotropin D. Antidiuretic hormone

Last Answer : A. Prolactin

Conversion of testosterone to estradiol requires the enzyme: (A) Aromatase (B) Dehydrogenase (C) Lyase (D) Isomerase HORMONE METABOLISM 215

Description : Conversion of testosterone to estradiol requires the enzyme: (A) Aromatase (B) Dehydrogenase (C) Lyase (D) Isomerase HORMONE METABOLISM 215

Last Answer : Answer : A

Which of the following is an amino acid derived hormone? (a) Epinephrine (b) Ecdysone (c) Estradiol (d) Estriol

Description : Which of the following is an amino acid derived hormone? (a) Epinephrine (b) Ecdysone (c) Estradiol (d) Estriol

Last Answer : (a) Epinephrine

Which of the following is an amino acid derived hormone ? (1) Epinephrine (2) Ecdysone (3) Estradiol (4) Estriol

Description : Which of the following is an amino acid derived hormone ? (1) Epinephrine (2) Ecdysone (3) Estradiol (4) Estriol

Last Answer : (1) Epinephrine

Young women are protected against myocardial infaracation because of the activity of (A) Estrogen (B) Progesterone (C) Growth hormone (D) Oxytocin

Description : Young women are protected against myocardial infaracation because of the activity of (A) Estrogen (B) Progesterone (C) Growth hormone (D) Oxytocin

Last Answer : Answer : A

Risk of neural tube defect in the offspring can be minimised in pregnant women receiving antiepileptic drugs by supplemental therapy with: A. Folic acid B. Vitamin A C. Vitamin E D. Pyridoxine

Description : Risk of neural tube defect in the offspring can be minimised in pregnant women receiving antiepileptic drugs by supplemental therapy with: A. Folic acid B. Vitamin A C. Vitamin E D. Pyridoxine

Last Answer : B. Vitamin A

What is true of docetaxel: A. It is used as a reserve drug for refractory breast and ovarian cancer B. It is a selective estrogen receptor modulator used for breast cancer C. It is effective only in estrogen receptor positive breast cancer D. Both 'B' and 'C' are correct

Description : What is true of docetaxel: A. It is used as a reserve drug for refractory breast and ovarian cancer B. It is a selective estrogen receptor modulator used for breast cancer C. It is effective only in estrogen receptor positive breast cancer D. Both 'B' and 'C' are correct

Last Answer : A. It is used as a reserve drug for refractory breast and ovarian cancer

The following contraceptive acts primarily by interfering with implantation of blastocyst: A. Gossypol B. Centchroman C. Combined estrogen-progestin pill D. Phased pill

Description : The following contraceptive acts primarily by interfering with implantation of blastocyst: A. Gossypol B. Centchroman C. Combined estrogen-progestin pill D. Phased pill

Last Answer : B. Centchroman

On stoppage of the combined estrogen-progestin contraceptive pill, fertility returns after: A. 1–2 months B. 4–6 months C. 6–12 months D. Uncertain period

Description : On stoppage of the combined estrogen-progestin contraceptive pill, fertility returns after: A. 1–2 months B. 4–6 months C. 6–12 months D. Uncertain period

Last Answer : A. 1–2 months

The currently used injectable hormonal contraceptive contains: A. Long acting progestin B. Long acting estrogen C. Both long acting estrogen and progestin D. Chorionic gonadotropin

Description : The currently used injectable hormonal contraceptive contains: A. Long acting progestin B. Long acting estrogen C. Both long acting estrogen and progestin D. Chorionic gonadotropin

Last Answer : A. Long acting progestin

The primary mechanism of action of the combined estrogen-progestin oral contraceptive pill is: A. Production of cervical mucus hostile to sperm penetration B. Suppression of FSH and LH release C. Making endometrium unsuitable for implantation D. Enhancing uterine contractions to dislodge the fertilized ovum

Description : The primary mechanism of action of the combined estrogen-progestin oral contraceptive pill is: A. Production of cervical mucus hostile to sperm penetration B. Suppression of FSH and ... Making endometrium unsuitable for implantation D. Enhancing uterine contractions to dislodge the fertilized ovum

Last Answer : B. Suppression of FSH and LH release

A progestin and an estrogen are combined in oral contraceptive pill because: A. The estrogen blocks the side effects of the progestin B. The progestin blocks the side effects of the estrogen C. Both synergise to suppress ovulation D. Both synergise to produce hostile cervical mucus

Description : A progestin and an estrogen are combined in oral contraceptive pill because: A. The estrogen blocks the side effects of the progestin B. The progestin blocks the side effects of the estrogen C. Both synergise to suppress ovulation D. Both synergise to produce hostile cervical mucus

Last Answer : C. Both synergise to suppress ovulation

The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are: A. Suppression of ovulation B. Prompt bleeding at the end of the course C. Blockade of increased risk of endometrial carcinoma D. All of the above

Description : The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are: A. Suppression of ovulation B. Prompt bleeding at the end of the course C. Blockade of increased risk of endometrial carcinoma D. All of the above

Last Answer : D. All of the above

The most popular form of hormonal contraception is: A. Combined estrogen + progestin oral pill B. Phased estrogen + progestin oral pill C. Postcoital estrogen + progestin pill D. Depot progestin injection

Description : The most popular form of hormonal contraception is: A. Combined estrogen + progestin oral pill B. Phased estrogen + progestin oral pill C. Postcoital estrogen + progestin pill D. Depot progestin injection

Last Answer : A. Combined estrogen + progestin oral pill

The distinctive features of desogestrel include the following except: A. It is a prodrug B. It has both strong progestational and strong antiovulatory activities C. It has additional androgenic acitivity D. It does not counteract the beneficial effect of estrogen on lipid profile

Description : The distinctive features of desogestrel include the following except: A. It is a prodrug B. It has both strong progestational and strong antiovulatory activities C. It has additional androgenic acitivity D. It does not counteract the beneficial effect of estrogen on lipid profile

Last Answer : C. It has additional androgenic acitivity

he distinctive features of desogestrel include the following except: A. It is a prodrug B. It has both strong progestational and strong antiovulatory activities C. It has additional androgenic acitivity D. It does not counteract the beneficial effect of estrogen on lipid profile

Description : he distinctive features of desogestrel include the following except: A. It is a prodrug B. It has both strong progestational and strong antiovulatory activities C. It has additional androgenic acitivity D. It does not counteract the beneficial effect of estrogen on lipid profile

Last Answer : C. It has additional androgenic acitivity

Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol

Description : Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol

Last Answer : . Ormeloxifen

The serum estradiol level in women during 21–30 days of menstrual cycle is (A) 10-20 pg/ml (B) 22-66 pg/ml (C) 73-149 pg/ml (D) 1000 pg/ml

Description : The serum estradiol level in women during 21–30 days of menstrual cycle is (A) 10-20 pg/ml (B) 22-66 pg/ml (C) 73-149 pg/ml (D) 1000 pg/ml

Last Answer : Answer : C

The serum estradiol level in women during 11–20 days of menstrual cycle is (A) 5–30 pg/ml (B) 50–300 pg/ml (C) 500–900 pg/ml (D) 1000 pg/ml

Description : The serum estradiol level in women during 11–20 days of menstrual cycle is (A) 5–30 pg/ml (B) 50–300 pg/ml (C) 500–900 pg/ml (D) 1000 pg/ml

Last Answer : Answer : B

The serum estradiol level in women during 1–10 days of menstrual cycle is (A) 0–10 pg/ml (B) 12–20 pg/ml (C) 24–68 pg/ml (D) 80–100 pg/ml

Description : The serum estradiol level in women during 1–10 days of menstrual cycle is (A) 0–10 pg/ml (B) 12–20 pg/ml (C) 24–68 pg/ml (D) 80–100 pg/ml

Last Answer : Answer : C

HRT patches... have any women used HRT patches to control menopausal hot flushes/night sweats... I would very much like to hear about your experiences?

Description : HRT patches... have any women used HRT patches to control menopausal hot flushes/night sweats... I would very much like to hear about your experiences?

Last Answer : answer:All my college classmates who tried HRT post-menopause stopped because of health issues. Live with the hot flashes, if you can. (That is what I did.) Carry a small, battery-operated portable fan, lots of kleenex and some hand towels. It will pass.